Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Paola Rogliani, Vito Brusasco, Leonardo Fabbri, Andrea Ungar, Elisa Muscianisi, Ilaria Barisone, Alberto Corsini & Giuseppe De Angelis. (2018) Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 12:2, pages 103-112.
Read now
Read now
R Andrew McIvor. (2008) Roflumilast: systemic therapy for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 2:5, pages 539-549.
Read now
Read now
Michael D VanAuker & Elizabeth Hood. (2008) Delivery strategies to target therapies to inflammatory tissue. Expert Opinion on Drug Delivery 5:7, pages 767-774.
Read now
Read now
Articles from other publishers (17)
Mayank Ajmera, Chan Shen & Usha Sambamoorthi. (2016) Association Between Statin Medications and COPD-Specific Outcomes: A Real-World Observational Study. Drugs - Real World Outcomes 4:1, pages 9-19.
Crossref
Crossref
Editorial Article. (2016) Therapeutic strategy to prevent acute exacerbations of chronic obstructive pulmonary disease: clinical guidelines of American College of Chest Physicians and Canadian Thoracic Society Guideline (Part 2). PULMONOLOGIYA 26:3, pages 267-291.
Crossref
Crossref
Gerard J. Criner, Jean Bourbeau, Rebecca L. Diekemper, Daniel R. Ouellette, Donna Goodridge, Paul Hernandez, Kristen Curren, Meyer S. Balter, Mohit Bhutani, Pat G. Camp, Bartolome R. Celli, Gail Dechman, Mark T. Dransfield, Stanley B. Fiel, Marilyn G. Foreman, Nicola A. Hanania, Belinda K. Ireland, Nathaniel Marchetti, Darcy D. Marciniuk, Richard A. Mularski, Joseph Ornelas, Jeremy D. Road & Michael K. Stickland. (2015) Prevention of Acute Exacerbations of COPD. Chest 147:4, pages 894-942.
Crossref
Crossref
Rama K. Krishna, Omar Issa, Debjit Saha, Francisco Yuri B. Macedo, Barbara Correal & Orlando Santana. (2015) Pleiotropic effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in pulmonary diseases: A comprehensive review. Pulmonary Pharmacology & Therapeutics 30, pages 134-140.
Crossref
Crossref
Taiji Goto, Akiko Shiina, Takeshi Murata, Masato Tomii, Takanori Yamazaki, Ken-ichi Yoshida, Toshiharu Yoshino, Osamu Suzuki, Yoshitaka Sogawa, Kiyoshi Mizukami, Nana Takagi, Tomomi Yoshitomi, Maki Etori, Hiroshi Tsuchida, Tsuyoshi Mikkaichi, Naoki Nakao, Mizuki Takahashi, Hisashi Takahashi & Shigeki Sasaki. (2014) Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors. Bioorganic & Medicinal Chemistry Letters 24:3, pages 893-899.
Crossref
Crossref
Gissela B Lieber, Xiomara Fernandez, Garfield G Mingo, Yanlin Jia, Michael Caniga, Malgorzata A. Gil, Shanil Keshwani, Janice D. Woodhouse, Milenko Cicmil, Lily Y Moy, Nancy Kelly, Johanna Jimenez, Yvette Crawley, John C Anthes, Joel Klappenbach, Yu-Lu Ma & Robbie L. McLeod. (2013) Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models. European Journal of Pharmacology 718:1-3, pages 290-298.
Crossref
Crossref
M Gabriella Matera, Luigino Calzetta, Barbara Rinaldi & Mario Cazzola. (2012) Treatment of COPD: moving beyond the lungs. Current Opinion in Pharmacology 12:3, pages 315-322.
Crossref
Crossref
Carlene MM Lawes, Simon Thornley, Robert Young, Raewyn Hopkins, Roger Marshall, Wing Cheuk Chan & Gary Jackson. (2012) Statin use in COPD patients is associated with a reduction in mortality: a national cohort study. Primary Care Respiratory Journal 21:1, pages 35-40.
Crossref
Crossref
Rachael A. Evans, Robert G. Varadi, Kambiz Mirzaei & Roger S. Goldstein. 2012. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease
211
252
.
Andrea Corsonello, Sabrina Garasto, Angela Marie Abbatecola, Giuseppina Rose, Giuseppe Passarino, Bruno Mazzei, Luigi Pranno, Enrico Eugenio Guffanti, Silvia Bustacchini & Fabrizia Lattanzio. (2010) Targeting inflammation to slow or delay functional decline: where are we?. Biogerontology 11:5, pages 603-614.
Crossref
Crossref
Shih-Feng LIU, Chien-Hung CHIN, Chin-Chou WANG & Meng-Chih LIN. (2009) Correlation between serum biomarkers and BODE index in patients with stable COPD. Respirology 14:7, pages 999-1004.
Crossref
Crossref
R P Young, R Hopkins & T E Eaton. (2009) Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence. Postgraduate Medical Journal 85:1006, pages 414-421.
Crossref
Crossref
M. W. Lawless, S. Norris, K. J. O’Byrne & S. G. Gray. (2009) Targeting histone deacetylases for the treatment of disease. Journal of Cellular and Molecular Medicine 13:5, pages 826-852.
Crossref
Crossref
Wim Janssens, An Lehouck, Claudia Carremans, Roger Bouillon, Chantal Mathieu & Marc Decramer. (2009) Vitamin D Beyond Bones in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 179:8, pages 630-636.
Crossref
Crossref
Charles Feldman. (2009) The Role of Statins in Respiratory Diseases. Clinical Pulmonary Medicine 16:2, pages 95-100.
Crossref
Crossref
Jane Hoover-Plow, Erika Hart, Yanqing Gong, Aleksey Shchurin & Tracey Schneeman. (2009) A Physiological Function for Apolipoprotein(a): A Natural Regulator of the Inflammatory Response. Experimental Biology and Medicine 234:1, pages 28-34.
Crossref
Crossref
Patricia Macedo & Omar S. Usmani. (2008) Inhaled Drug Therapy in Chronic Obstructive Pulmonary Disease. Clinical Pulmonary Medicine 15:5, pages 239-247.
Crossref
Crossref